PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-18.51%
Negative net income growth while BB stands at 7.51%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-23.38%
Negative yoy D&A while BB is 1.76%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-259.41%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-27.24%
Negative yoy SBC while BB is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
158.03%
Well above BB's 260.46% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
148.31%
AR growth of 148.31% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
226.67%
Growth well above BB's 365.90%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
32.50%
Lower 'other non-cash' growth vs. BB's 176.98%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
104.53%
Some CFO growth while BB is negative at -14.78%. John Neff would note a short-term liquidity lead over the competitor.
5.03%
Lower CapEx growth vs. BB's 50.18%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-31.75%
Both yoy lines negative, with BB at -99.97%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
37.58%
Some yoy expansion while BB is negative at -67.51%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-57.10%
Both yoy lines are negative, with BB at -52.46%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-87.55%
Both yoy lines negative, with BB at -1554.25%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.12%
Buyback growth of 37.12% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.